- Home
- OPK vs BCSF Comparison
OPK vs BCSF Comparison
Compare OPK & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- BCSF
- Stock Information
- Founded
- OPK 2007
- BCSF 2015
- Country
- OPK United States
- BCSF United States
- Employees
- OPK N/A
- BCSF N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- BCSF Finance/Investors Services
- Sector
- OPK Health Care
- BCSF Finance
- Exchange
- OPK Nasdaq
- BCSF Nasdaq
- Market Cap
- OPK 1.0B
- BCSF 983.4M
- IPO Year
- OPK 1995
- BCSF 2018
- Fundamental
- Price
- OPK $1.46
- BCSF $14.80
- Analyst Decision
- OPK Buy
- BCSF Buy
- Analyst Count
- OPK 4
- BCSF 2
- Target Price
- OPK $2.75
- BCSF $16.50
- AVG Volume (30 Days)
- OPK 2.0M
- BCSF 275.5K
- Earning Date
- OPK 11-06-2025
- BCSF 11-04-2025
- Dividend Yield
- OPK N/A
- BCSF 12.24%
- EPS Growth
- OPK N/A
- BCSF N/A
- EPS
- OPK N/A
- BCSF 1.66
- Revenue
- OPK $664,029,000.00
- BCSF $283,687,000.00
- Revenue This Year
- OPK N/A
- BCSF N/A
- Revenue Next Year
- OPK $0.84
- BCSF N/A
- P/E Ratio
- OPK N/A
- BCSF $8.84
- Revenue Growth
- OPK N/A
- BCSF N/A
- 52 Week Low
- OPK $1.11
- BCSF $13.20
- 52 Week High
- OPK $2.04
- BCSF $19.21
- Technical
- Relative Strength Index (RSI)
- OPK 61.87
- BCSF 37.02
- Support Level
- OPK $1.34
- BCSF $14.51
- Resistance Level
- OPK $1.44
- BCSF $14.91
- Average True Range (ATR)
- OPK 0.04
- BCSF 0.24
- MACD
- OPK 0.00
- BCSF -0.12
- Stochastic Oscillator
- OPK 92.69
- BCSF 20.30
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.